0001382963-15-000082.txt : 20150630
0001382963-15-000082.hdr.sgml : 20150630
20150630200937
ACCESSION NUMBER: 0001382963-15-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150629
FILED AS OF DATE: 20150630
DATE AS OF CHANGE: 20150630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RITTER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001460702
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263474527
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1801 CENTURY PARK EAST, SUITE 1820
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
BUSINESS PHONE: 310-203-1000
MAIL ADDRESS:
STREET 1: 1801 CENTURY PARK EAST, SUITE 1820
CITY: LOS ANGELES
STATE: CA
ZIP: 90067
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ritter Ira E.
CENTRAL INDEX KEY: 0001631674
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37428
FILM NUMBER: 15962853
MAIL ADDRESS:
STREET 1: C/O RITTER PHARMACEUTICALS INC.
STREET 2: 1801 CENTURY PARK EAST, SUITE 1820
CITY: LOS ANGELES
STATE: CA
ZIP: 90096
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-06-29
0001460702
RITTER PHARMACEUTICALS INC
RTTR
0001631674
Ritter Ira E.
RITTER PHARMACEUTICALS, INC.
1801 CENTURY PARK EAST, #1820
LOS ANGELES
CA
90067
1
1
0
0
Exec. Chairman, CSO
Common Stock
2015-06-29
4
C
0
817272
A
817272
I
by Stonehenge Partners LLC
Convertible Preferred Stock
2015-06-29
4
C
0
817272
0
D
Common Stock
817272
0
I
by Stonehenge Partners LLC
Effective on the date of the closing of the issuer's initial public offering, the Convertible Preferred Stock of the issuer held by Stonehenge Partners LLC converted into Common Stock of the issuer on a one-for-one basis and had no expiration date.
As a managing partner of Stonehenge Partners LLC, the reporting person may be deemed the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.
/s/Andrew J. Ritter, attorney-in-fact
2015-06-30